A citation-based method for searching scientific literature

Yasin Bhanji, William B Isaacs, Jianfeng Xu, Kathleen A Cooney. Urol Clin North Am 2021
Times Cited: 3







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


ClinGen Variant Curation Expert Panel experiences and standardized processes for disease and gene-level specification of the ACMG/AMP guidelines for sequence variant interpretation.
Edgar A Rivera-Muñoz, Laura V Milko, Steven M Harrison, Danielle R Azzariti, C Lisa Kurtz, Kristy Lee, Jessica L Mester, Meredith A Weaver, Erin Currey, William Craigen,[...]. Hum Mutat 2018
51
33

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
James L Mohler, Emmanuel S Antonarakis, Andrew J Armstrong, Anthony V D'Amico, Brian J Davis, Tanya Dorff, James A Eastham, Charles A Enke, Thomas A Farrington, Celestia S Higano,[...]. J Natl Compr Canc Netw 2019
506
33

A Population-Based Study of Genes Previously Implicated in Breast Cancer.
Chunling Hu, Steven N Hart, Rohan Gnanaolivu, Hongyan Huang, Kun Y Lee, Jie Na, Chi Gao, Jenna Lilyquist, Siddhartha Yadav, Nicholas J Boddicker,[...]. N Engl J Med 2021
66
33

Pan-Cancer Analysis of BRCA1 and BRCA2 Genomic Alterations and Their Association With Genomic Instability as Measured by Genome-Wide Loss of Heterozygosity.
Ethan S Sokol, Dean Pavlick, Hossein Khiabanian, Garrett M Frampton, Jeffrey S Ross, Jeffrey P Gregg, Primo N Lara, Steffi Oesterreich, Neeraj Agarwal, Andrea Necchi,[...]. JCO Precis Oncol 2020
25
33

Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic Panel.
Daniel A Leongamornlert, Edward J Saunders, Sarah Wakerell, Ian Whitmore, Tokhir Dadaev, Clara Cieza-Borrella, Sarah Benafif, Mark N Brook, Jenny L Donovan, Freddie C Hamdy,[...]. Eur Urol 2019
29
33

The homeodomain protein HOXB13 regulates the cellular response to androgens.
John D Norris, Ching-Yi Chang, Bryan M Wittmann, Rebecca S Kunder, Huaxia Cui, Daju Fan, James D Joseph, Donald P McDonnell. Mol Cell 2009
136
33

Evaluating the Clinical Validity of Gene-Disease Associations: An Evidence-Based Framework Developed by the Clinical Genome Resource.
Natasha T Strande, Erin Rooney Riggs, Adam H Buchanan, Ozge Ceyhan-Birsoy, Marina DiStefano, Selina S Dwight, Jenny Goldstein, Rajarshi Ghosh, Bryce A Seifert, Tam P Sneddon,[...]. Am J Hum Genet 2017
191
33

Inherited NBN Mutations and Prostate Cancer Risk and Survival.
Bogna Rusak, Wojciech Kluźniak, Dominika Wokołorczykv, Klaudia Stempa, Aniruddh Kashyap, Jacek Gronwald, Tomasz Huzarski, Tadeusz Dębniak, Anna Jakubowska, Bartłomiej Masojć,[...]. Cancer Res Treat 2019
12
33

Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.
Rong Na, S Lilly Zheng, Misop Han, Hongjie Yu, Deke Jiang, Sameep Shah, Charles M Ewing, Liti Zhang, Kristian Novakovic, Jacqueline Petkewicz,[...]. Eur Urol 2017
163
33

The UK Biobank resource with deep phenotyping and genomic data.
Clare Bycroft, Colin Freeman, Desislava Petkova, Gavin Band, Lloyd T Elliott, Kevin Sharp, Allan Motyer, Damjan Vukcevic, Olivier Delaneau, Jared O'Connell,[...]. Nature 2018
33

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
Joaquin Mateo, Suzanne Carreira, Shahneen Sandhu, Susana Miranda, Helen Mossop, Raquel Perez-Lopez, Daniel Nava Rodrigues, Dan Robinson, Aurelius Omlin, Nina Tunariu,[...]. N Engl J Med 2015
33

Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.
Piper Nicolosi, Elisa Ledet, Shan Yang, Scott Michalski, Brandy Freschi, Erin O'Leary, Edward D Esplin, Robert L Nussbaum, Oliver Sartor. JAMA Oncol 2019
91
33

Germline Pathogenic Variants in 7636 Japanese Patients With Prostate Cancer and 12 366 Controls.
Yukihide Momozawa, Yusuke Iwasaki, Makoto Hirata, Xiaoxi Liu, Yoichiro Kamatani, Atsushi Takahashi, Kokichi Sugano, Teruhiko Yoshida, Yoshinori Murakami, Koichi Matsuda,[...]. J Natl Cancer Inst 2020
25
33

Transcript expression-aware annotation improves rare variant interpretation.
Beryl B Cummings, Konrad J Karczewski, Jack A Kosmicki, Eleanor G Seaby, Nicholas A Watts, Moriel Singer-Berk, Jonathan M Mudge, Juha Karjalainen, F Kyle Satterstrom, Anne H O'Donnell-Luria,[...]. Nature 2020
39
33

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
Colin C Pritchard, Joaquin Mateo, Michael F Walsh, Navonil De Sarkar, Wassim Abida, Himisha Beltran, Andrea Garofalo, Roman Gulati, Suzanne Carreira, Rosalind Eeles,[...]. N Engl J Med 2016
699
33

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
33

Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.
Leila Dorling, Sara Carvalho, Jamie Allen, Anna González-Neira, Craig Luccarini, Cecilia Wahlström, Karen A Pooley, Michael T Parsons, Cristina Fortuno, Qin Wang,[...]. N Engl J Med 2021
87
33

Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.
Veda N Giri, Karen E Knudsen, William K Kelly, Heather H Cheng, Kathleen A Cooney, Michael S Cookson, William Dahut, Scott Weissman, Howard R Soule, Daniel P Petrylak,[...]. J Clin Oncol 2020
63
33

Diagnosing hereditary cancer predisposition in men with prostate cancer.
Mary Pritzlaff, Yuan Tian, Patrick Reineke, A J Stuenkel, Kyle Allen, Stephanie Gutierrez, Michelle Jackson, Jill S Dolinsky, Holly LaDuca, Jianfeng Xu,[...]. Genet Med 2020
14
33

Combined Effect of a Polygenic Risk Score and Rare Genetic Variants on Prostate Cancer Risk.
Burcu F Darst, Xin Sheng, Rosalind A Eeles, Zsofia Kote-Jarai, David V Conti, Christopher A Haiman. Eur Urol 2021
3
33

Updated insights into genetic contribution to prostate cancer predisposition: focus on HOXB13.
William B Isaacs, Kathleen A Cooney, Jianfeng Xu. Can J Urol 2019
5
33

NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.
Peter R Carroll, J Kellogg Parsons, Gerald Andriole, Robert R Bahnson, Erik P Castle, William J Catalona, Douglas M Dahl, John W Davis, Jonathan I Epstein, Ruth B Etzioni,[...]. J Natl Compr Canc Netw 2016
204
33

Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer.
Tamara L Lotan, Harsimar B Kaur, Daniela C Salles, Sanjana Murali, Edward M Schaeffer, Jerry S Lanchbury, William B Isaacs, Robert Brown, Andrea L Richardson, Olivier Cussenot,[...]. Mod Pathol 2021
7
33

A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD).
Luisa Santangelo, Maddalena Gigante, Giuseppe Stefano Netti, Sterpeta Diella, Flora Puteo, Vincenza Carbone, Giuseppe Grandaliano, Mario Giordano, Loreto Gesualdo. BMC Nephrol 2014
17
33

Enzymatically active prostate-specific antigen promotes growth of human prostate cancers.
Simon A Williams, Christine A Jelinek, Ivan Litvinov, Robert J Cotter, John T Isaacs, Samuel R Denmeade. Prostate 2011
34
33

A complex secretory program orchestrated by the inflammasome controls paracrine senescence.
Juan Carlos Acosta, Ana Banito, Torsten Wuestefeld, Athena Georgilis, Peggy Janich, Jennifer P Morton, Dimitris Athineos, Tae-Won Kang, Felix Lasitschka, Mindaugas Andrulis,[...]. Nat Cell Biol 2013
878
33

Integrated molecular analysis of clear-cell renal cell carcinoma.
Yusuke Sato, Tetsuichi Yoshizato, Yuichi Shiraishi, Shigekatsu Maekawa, Yusuke Okuno, Takumi Kamura, Teppei Shimamura, Aiko Sato-Otsubo, Genta Nagae, Hiromichi Suzuki,[...]. Nat Genet 2013
639
33

Pre-analytical-related variability influencing serum peptide profiles demonstrated in a mass spectrometry-based search for colorectal and prostate cancer biomarkers.
Jakub Karczmarski, Tymon Rubel, Michal Mikula, Jan Wolski, Andrzej Rutkowski, Edyta Zagorowicz, Michal Dadlez, Jerzy Ostrowski. Acta Biochim Pol 2013
10
33

Indications and results of renal biopsy in children: a 36-year experience.
Luisa Santangelo, Giuseppe Stefano Netti, Paolo Giordano, Vincenza Carbone, Marida Martino, Diletta Domenica Torres, Michele Rossini, Anna Maria Di Palma, Loreto Gesualdo, Mario Giordano. World J Pediatr 2018
8
33

Cellular senescence and the senescent secretory phenotype: therapeutic opportunities.
Tamara Tchkonia, Yi Zhu, Jan van Deursen, Judith Campisi, James L Kirkland. J Clin Invest 2013
841
33


Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomy.
Chuanliang Xu, Monika Jung, Mick Burkhardt, Carsten Stephan, Dietmar Schnorr, Stefan Loening, Klaus Jung, Manfred Dietel, Glen Kristiansen. Prostate 2005
29
33

Complement. Second of two parts.
M J Walport. N Engl J Med 2001
33

PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer.
Eduardo Bonavita, Stefania Gentile, Marcello Rubino, Virginia Maina, Roberto Papait, Paolo Kunderfranco, Carolina Greco, Francesca Feruglio, Martina Molgora, Ilaria Laface,[...]. Cell 2015
217
33

MAp19, the alternative splice product of the MASP2 gene.
Søren E Degn, Steffen Thiel, Ole Nielsen, Annette G Hansen, Rudi Steffensen, Jens C Jensenius. J Immunol Methods 2011
43
33

The Role of PTX3 in Mineralization Processes and Aging-Related Bone Diseases.
Umberto Tarantino, Chiara Greggi, Ida Cariati, Virginia Veronica Visconti, Monica Gasparini, Marco Cateni, Elena Gasbarra, Annalisa Botta, Antonietta Salustri, Manuel Scimeca. Front Immunol 2021
4
33

A possible role of CD46 for the protection in vivo of human renal tumor cells from complement-mediated damage.
V T Blok, M R Daha, O M Tijsma, M G Weissglas, L J van den Broek, A Gorter. Lab Invest 2000
40
33

PTX3 acts as an extrinsic oncosuppressor.
Eduardo Bonavita, Alberto Mantovani, Cecilia Garlanda. Oncotarget 2015
6
33

Increased expression of C5a receptor (CD88) mRNA in canine mammary tumors.
Mohd Noor Mohd Hezmee, Myat Kyaw-Tanner, Jia Yu Peppermint Lee, Ian A Shiels, Barbara Rolfe, Trent Woodruff, Paul C Mills. Vet Immunol Immunopathol 2011
5
33

Complement as Prognostic Biomarker and Potential Therapeutic Target in Renal Cell Carcinoma.
Britney Reese, Ashok Silwal, Elizabeth Daugherity, Michael Daugherity, Mahshid Arabi, Pierce Daly, Yvonne Paterson, Layton Woolford, Alana Christie, Roy Elias,[...]. J Immunol 2020
6
33

The Pathogenic Role of PI3K/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review.
Federica Rascio, Federica Spadaccino, Maria Teresa Rocchetti, Giuseppe Castellano, Giovanni Stallone, Giuseppe Stefano Netti, Elena Ranieri. Cancers (Basel) 2021
5
33


Is complement good or bad for cancer patients? A new perspective on an old dilemma.
Maciej M Markiewski, John D Lambris. Trends Immunol 2009
108
33

Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2.
Marco Presta, Eleonora Foglio, Ander Churruca Schuind, Roberto Ronca. Front Immunol 2018
26
33

Complement activation determines the therapeutic activity of rituximab in vivo.
Nicola Di Gaetano, Elena Cittera, Rachele Nota, Annunciata Vecchi, Valeria Grieco, Eugenio Scanziani, Marina Botto, Martino Introna, Josée Golay. J Immunol 2003
389
33

The complement system in cancer: Ambivalence between tumour destruction and promotion.
Srinivas Mamidi, Simon Höne, Michael Kirschfink. Immunobiology 2017
66
33

Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor.
Jean-Philippe Coppé, Christopher K Patil, Francis Rodier, Yu Sun, Denise P Muñoz, Joshua Goldstein, Peter S Nelson, Pierre-Yves Desprez, Judith Campisi. PLoS Biol 2008
33

Epidemiology of Prostate Cancer.
Prashanth Rawla. World J Oncol 2019
450
33

Complement. First of two parts.
M J Walport. N Engl J Med 2001
33

High Level of Anaphylatoxin C5a Predicts Poor Clinical Outcome in Patients with Clear Cell Renal Cell Carcinoma.
Wei Xi, Li Liu, Jiajun Wang, Yu Xia, Qi Bai, Qilai Long, Yiwei Wang, Jiejie Xu, Jianming Guo. Sci Rep 2016
11
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.